{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:26:42Z","timestamp":1792715202697,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2020,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/modpathol.2017.16","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T08:41:04Z","timestamp":1489740064000},"page":"1021-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Evaluation of p16\/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women"],"prefix":"10.1016","volume":"30","author":[{"given":"Ren\u00e9e MF","family":"Ebisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meyke","family":"Hermsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Lucia","family":"Rijstenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith EM","family":"Vedder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remko P","family":"Bosgraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola MJ","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle AM","family":"Heideman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter JF","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris JLM","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-4354","authenticated-orcid":false,"given":"Folkert J","family":"van Kemenade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon FAG","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem JG","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud LM","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert G","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.16_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2017.16_bib2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/bmj.308.6941.1407","article-title":"Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease","volume":"308","author":"Macgregor","year":"1994","journal-title":"BMJ"},{"key":"10.1038\/modpathol.2017.16_bib3","first-page":"471","article-title":"Effect of a mass screening program on the risk of cervical cancer","volume":"15","author":"Louhivuori","year":"1991","journal-title":"Cancer Detect Prev"},{"key":"10.1038\/modpathol.2017.16_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlledtrial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2017.16_bib5","first-page":"147","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/modpathol.2017.16_bib6","doi-asserted-by":"crossref","first-page":"S3\/78","DOI":"10.1016\/j.vaccine.2006.05.117","article-title":"Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"10.1038\/modpathol.2017.16_bib7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14737140.2016.1232166","article-title":"Triage of high-risk HPV positive women in cervical cancer screening","volume":"16","author":"Ebisch","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1038\/modpathol.2017.16_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/lgt.0b013e31815ea58b","article-title":"Risk assessment to guide the prevention of cervical cancer","volume":"12","author":"Castle","year":"2008","journal-title":"J Low Genit Trac Dis"},{"key":"10.1038\/modpathol.2017.16_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.30090","article-title":"The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples","volume":"139","author":"Ebisch","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2017.16_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary high-risk HPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1038\/modpathol.2017.16_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2017.16_bib12","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0959-8049(02)00462-8","article-title":"New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections","volume":"38","author":"von Knebel Doeberitz","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2017.16_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14737140.2014.856273","article-title":"The current position and the future perspectives of cervical cancer screening","volume":"14","author":"Bosgraaf","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1038\/modpathol.2017.16_bib14","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/jnci\/djt235","article-title":"Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study","volume":"105","author":"Ikenberg","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2017.16_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2017.16_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.20140","article-title":"p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study","volume":"119","author":"Schmidt","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/modpathol.2017.16_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncy.21233","article-title":"Evaluation of p16(INK4a)\/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion","volume":"121","author":"Waldstrom","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/modpathol.2017.16_bib18","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.16_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0b013e31828aeb39","article-title":"Improved abnormal Pap smear triage using cervical cancer biomarkers","volume":"18","author":"Killeen","year":"2014","journal-title":"J Low Genit Tract Dis"},{"key":"10.1038\/modpathol.2017.16_bib20","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/bjc.2014.34","article-title":"Triaging borderline\/mild dyskaryotic Pap cytology with p16\/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study","volume":"110","author":"Uijterwaal","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2017.16_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ijc.30449","article-title":"Good performance of p16\/Ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN","volume":"140","author":"Polman","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2017.16_bib22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/modpathol.2016.80","article-title":"p16\/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population","volume":"29","author":"Luttmer","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.16_bib23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ijc.29026","article-title":"Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening","volume":"136","author":"Bosgraaf","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2017.16_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jcp.2003.011841","article-title":"The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996","volume":"57","author":"Bulk","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2017.16_bib25","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"key":"10.1038\/modpathol.2017.16_bib26","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1128\/JCM.05552-11","article-title":"Clinical validation of the cobas 4800 HPV test for cervical screening purposes","volume":"49","author":"Heideman","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1038\/modpathol.2017.16_bib27","unstructured":"R Core Team. R: a language and environment for statistical computing Available at: http:\/\/CRAN.R-project.org\/package=DTComPair. Accessed on 24 August 2016."},{"key":"10.1038\/modpathol.2017.16_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ajcp\/aqv019","article-title":"Use of cytology, E6\/E7 mRNA, and p16INK4a-Ki-67 to define the management of human papillomavirus (HPV)-positive women in cervical cancer screening","volume":"145","author":"Gustinucci","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.16_bib29","doi-asserted-by":"crossref","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2017.16_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/cncy.21511","article-title":"Interpretation of p16(INK4a) \/Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology","volume":"123","author":"Allia","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/modpathol.2017.16_bib31","doi-asserted-by":"crossref","first-page":"21181","DOI":"10.18632\/oncotarget.8307","article-title":"Evaluation of p16\/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2017.16_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1038\/modpathol.2017.16_bib33","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/ijc.29290","article-title":"Triaging HPV-positive women with normal cytology by p16\/Ki-67 dual-stained cytology testing: baseline and longitudinal data","volume":"136","author":"Uijterwaal","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2017.16_bib34","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/cncy.21473","article-title":"Interobserver reproducibility and accuracy of p16\/Ki-67 dual-stain cytology in cervical cancer screening","volume":"122","author":"Wentzensen","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/modpathol.2017.16_bib35","article-title":"Interobserver reproducibility of cytologic p16INK4a \/Ki-67 dual immunostaining in human papillomavirus-positivewomen","author":"Benevolo","year":"2017","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2017.16_bib36","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/JCM.02440-05","article-title":"High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush","volume":"44","author":"Brink","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1038\/modpathol.2017.16_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2017.16_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2017.16_bib39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jnci\/djs135","article-title":"Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population","volume":"104","author":"Mirabello","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2017.16_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/bjc.2016.200","article-title":"FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women","volume":"115","author":"Luttmer","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2017.16_bib41","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737159.2016.1217157","article-title":"Management of high-risk HPV-positive women for detection of cervical (pre)cancer","volume":"16","author":"Luttmer","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1038\/modpathol.2017.16_bib42","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.5858\/arpa.2012-0115-CP","article-title":"The Tahoe Study: bias in the interpretation of Papanicolaou test results when human papillomavirus status is known","volume":"138","author":"Moriarty","year":"2014","journal-title":"Arch Pathol Lab Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201716","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:39:27Z","timestamp":1760229567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222007827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0893395222007827"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.16","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of p16\/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.16","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}